ABOUT
OUR MISSION
To translate emerging biology into therapies that improve outcomes for patients with neurodegenerative diseases.
ABOUT
Founded on a conviction
Biocient was founded on the conviction that mitochondrial dysfunction is a key contributor to neurodegenerative disease — and that addressing it may create new opportunities for therapeutic intervention.

Our research combines advances in mitochondrial biology, translational science, and preclinical development to uncover therapies that target the underlying causes of disease rather than its symptoms.
LEADERSHIP
Our core team
The smartest people work every day to provide the best service and make our clients happy
Roman Pipman
Founder & Chief Executive Officer
Roman Pipman is an entrepreneur and executive in health and life sciences with more than 30 years of experience building, financing, and scaling companies across Europe and North America.
He previously led the development and commercialization of Amberen, a leading women's health product, which was acquired by Alliance Pharma. Biocient reflects his commitment to advancing innovative therapies that address significant unmet medical needs.
Luis Pérez de Sevilla Müller, PhD
Chief Scientific Officer
Dr. Luis Pérez de Sevilla is a neuroscientist focused on retinal biology, neurodegeneration, and the cellular and molecular mechanisms of neurological disease. His work uses genetic models, electrophysiology, and advanced imaging to investigate disease pathology and potential therapeutic targets.
His career includes extensive research in Canada, Germany, and the USA, most recently at UCLA prior to joining Biocient, along with numerous peer-reviewed publications investigating retinal and neuronal function. At Biocient, Dr. Pérez de Sevilla leads scientific strategy and preclinical development efforts focused on mitochondrial biology and neurodegenerative disease.
Roman Pipman
Founder & Chief Executive Officer
Roman Pipman is an entrepreneur and executive in health and life sciences with more than 30 years of experience building, financing, and scaling companies across Europe and North America.
He previously led the development and commercialization of Amberen, a leading women's health product, which was acquired by Alliance Pharma. Biocient reflects his commitment to advancing innovative therapies that address significant unmet medical needs.
  • Max Holden
    Founder & Art Director
    Roman Pipman is an entrepreneur and executive in health and life sciences with more than 30 years of experience building, financing, and scaling companies across Europe and North America.

    He previously led the development and commercialization of Amberen, a leading women's health product, which was acquired by Alliance Pharma. Biocient reflects his commitment to advancing innovative therapies that address significant unmet medical needs.
  • Eva Stark
    Customer Support
    Julia takes care of everything you can see. She spent five years in London learning visual communication. She uses her knowledge to make the world a little more beautiful.
  • Julia Bush
    Design Director
    Max founded our company. He is the father of our main goals and values. He found the core members of our team and helped them to show their unique talents in the work process.
  • Carlos Lott
    Marketing Director
    Max founded our company. He is the father of our main goals and values. He found the core members of our team and helped them to show their unique talents in the work process.
Contact us:
© 2026 Biocient Inc. All Rights Reserved.